Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced ...
Members of our Community Editorial Board, a group of community residents who are engaged with and passionate about local issues, respond to the following question: Boulder officials have greenlit new ...